Sex Steroids and Cancer

American Cancer Society, 1986, Cancer statistics 1987, CA, 36, 2 Bland, 1980, The effects of exogenous estrogen replacement therapy on the breast: breast cancer risk and mammographic parenchymal patterns, Cancer, 45, 3027, 10.1002/1097-0142(19800615)45:12<3027::AID-CNCR2820451225>3.0.CO;2-2 Boston Collaborative Drug Surveillance Program, 1974, Surgically confirmed gallbladder disease, venous thromboembolism and breast tumors in relation to postmenopausal estrogen therapy, N Engl J Med, 290, 15, 10.1056/NEJM197401032900104 Brinton, 1981, Menopausal estrogen use and risk of breast cancer, Cancer, 47, 2517, 10.1002/1097-0142(19810515)47:10<2517::AID-CNCR2820471035>3.0.CO;2-L Burch, 1976, Results of estrogen treatment in one thousand hysterectomized women for 14,318 years Casagrande, 1976, Exogenous estrogens and breast cancer in women with natural menopause, J Natl Cancer Inst, 56, 839, 10.1093/jnci/56.4.839 Clark, 1983, Progesterone receptor as a prognostic factor in Stage II breast cancer, N Engl J Med, 309, 1343, 10.1056/NEJM198312013092240 Coulan, 1983, Chronic anovulation may increase postmenopausal breast cancer risk, JAMA, 249, 445, 10.1001/jama.1983.03330280003002 Cowan, 1981, Breast cancer incidence in women with a history of progesterone deficiency, Am J Epidemiol, 114, 209, 10.1093/oxfordjournals.aje.a113184 Craig, 1974, Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls, J Natl Cancer Inst, 53, 1577 Gambrell, 1982, Clinical use of progestins in the menopausal patient, J Reprod Med, 27, 531 Gambrell, 1983, Breast disease in tire postmenopausal years, Semin Reprod Endocrinol, 1, 27, 10.1055/s-2007-1022573 Gambrell, 1984, Sex Steroid Hormones and Cancer Gambrell, 1986, Prevention of endometrial cancer with progestogens, Maturitas, 8, 159, 10.1016/0378-5122(86)90022-8 Gambrell, 1986, Role of progestogens in prevention of breast cancer, Maturitas, 8, 169, 10.1016/0378-5122(86)90023-X Gambrell RD Jr: Studies of endometrial and breast disease with hormone replacement therapy. In Studd JWW, Whitehead M (eds): The Menopause. Oxford, Blackwell Scientific Publications, Ltd, in press Gambrell, 1980, Use of the progestogen challenge test to reduce the risk of endometrial cancer, Obstet Gynecol, 55, 732 Gusberg, 1976, The individual at high-risk for endometrial carcinoma, Am J Obstet Gynecol, 126, 535, 10.1016/0002-9378(76)90744-4 Hammond, 1979, Effects of long term estrogen replacement therapy. II. Neoplasia, Am J Obstet Gynecol, 133, 537, 10.1016/0002-9378(79)90289-8 Henderson, 1974, An epidemiologic study of breast cancer, J Natl Cancer Inst, 53, 609, 10.1093/jnci/53.3.609 Hoover, 1976, Menopausal estrogens and breast cancer, N Engl J Med, 295, 401, 10.1056/NEJM197608192950801 Hoover, 1981, Conjugated estrogens and breast cancer risk in women, J Natl Cancer Inst, 67, 815 Hulka, 1984, When is the evidence for 'no association’ sufficient?, JAMA, 252, 81, 10.1001/jama.1984.03350010047022 Hulka, 1982, Breast cancer and estrogen replacement therapy, Am J Obstet Gynecol, 143, 638, 10.1016/0002-9378(82)90108-9 Jick, 1980, Replacement estrogens and breast cancer, Am J Epidemiol, 112, 586, 10.1093/oxfordjournals.aje.a113031 Kaufman, 1984, Noncontraceptive estrogen use and the risk of breast cancer, JAMA, 252, 63, 10.1001/jama.1984.03350010029018 Kelsey, 1981, Exogenous estrogens and other factors in the epidemiology of breast cancer, J Natl Cancer Inst, 67, 327 Korenman, 1980, The endocrinology of breast cancer, Cancer, 46, 874, 10.1002/1097-0142(19800815)46:4+<874::AID-CNCR2820461305>3.0.CO;2-# Lauritzen, 1984, Risks of endometrial and mammary cancer morbidity and mortality in long-term estrogen treatment Magos, 1985, Amenorrhea and endometrial atrophy following continuous oral estrogen and progestogen therapy in postmenopausal women, Obstet Gynecol, 65, 496 Nachtigall, 1979, Estrogen replacement. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems, Obstet Gynecol, 54, 74, 10.1097/00006250-197907000-00017 National Cancer Institute, 1980 Ross, 1980, A case-control study of menopausal estrogen therapy and breast cancer, JAMA, 243, 1635, 10.1001/jama.1980.03300420019018 Sartwell, 1977, Exogenous hormones, reproductive history, and breast cancer, J Natl Cancer Inst, 59, 1589, 10.1093/jnci/59.6.1589 Shapiro, 1985, Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens, N Engl J Med, 313, 969, 10.1056/NEJM198510173131601 Sherman, 1983, Estrogen use and breast cancer: interaction with body mass, Cancer, 51, 1527, 10.1002/1097-0142(19830415)51:8<1527::AID-CNCR2820510828>3.0.CO;2-T Sturdee, 1978, Relationships between bleeding pattern, endometrial histology and oestrogen treatment in menopausal women, Br Med J, 1, 1575, 10.1136/bmj.1.6127.1575 Thom, 1979, Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy, Lancet, 2, 455, 10.1016/S0140-6736(79)91504-6 Vessey, 1984, Exogenous hormones in the oetiology of cancer in women, J Roy Soc Med, 77, 542, 10.1177/014107688407700704 Volker, 1980, Estrogen and estrogen-progestogen compounds: is there a risk for the development of endometrial and breast cancer in the perimenopausal women? Wentz, 1974, Progestin therapy in endometrial hyperplasia, Gynecol Oncol, 2, 362, 10.1016/0090-8258(74)90027-4 Whitehead, 1981, Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium, N Engl J Med, 305, 1599, 10.1056/NEJM198112313052701 Wynder, 1978, The epidemiology of breast cancer in 785 United States caucasian women, Cancer, 41, 2341, 10.1002/1097-0142(197806)41:6<2341::AID-CNCR2820410637>3.0.CO;2-N